Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Clark

Showing results (11-20 of 115) with videos related to

Pageof 12
Sort By:
Cardiovascular Diseases|January 1, 1974
LEAFLET PROSTHETIC VALVESRichard E. Clark, Phillip L. Gould, W Milton Swanson
Blood|August 19, 2004
Active transport of imatinib into and out of cells: implications for drug resistanceJulia Thomas, Lihui Wang, Richard E Clark, et al.
Leukemia & Lymphoma|April 10, 2008
Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemiaRichard E Clark, Andrea Davies, Munir Pirmohamed, et al.
Haematologica|February 8, 2006
The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemiaLihui Wang, Katy Knight, Claire Lucas, et al.
Nucleic Acids Research|April 25, 2003
CpG oligodeoxynucleotide 5mer-induced apoptosis in MOLT-4 leukaemia cells does not require caspase 3 or new protein synthesisDavid M Tidd, Caroline M Broughton, Richard E Clark
British Journal of Haematology|March 22, 2003
The early molecular response to imatinib predicts cytogenetic and clinical outcome in chronic myeloid leukaemiaLihui Wang, Kevin Pearson, Julia E Ferguson, et al.
Blood Advances|February 22, 2021
Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progressionRichard E Clark, Jane F Apperley, Mhairi Copland, et al.
European Journal of Haematology|July 22, 2014
Evidence that the pregnane X and retinoid receptors PXR, RAR and RXR may regulate transcription of the transporter hOCT1 in chronic myeloid leukaemia cellsGemma Austin, Alison Holcroft, Natasha Rinne, et al.
Leukemia Research|January 21, 2009
T cell function in chronic myeloid leukemia and its treatment with tyrosine kinase inhibitors--clues from and for sarcoidosisMaqsood Punekar, Jecko Thachil, Rahuman Salim, et al.
Blood|January 15, 2020
Molecular monitoring during dose reduction predicts recurrence after TKI cessation in CMLAndrea Gottschalk, Ingmar Glauche, Silvia Cicconi, et al.
Pageof 12

Showing results (11-20 of 115) with videos related to

Sort By:
Pageof 12
Cardiovascular Diseases|January 1, 1974
LEAFLET PROSTHETIC VALVESRichard E. Clark, Phillip L. Gould, W Milton Swanson
Blood|August 19, 2004
Active transport of imatinib into and out of cells: implications for drug resistanceJulia Thomas, Lihui Wang, Richard E Clark, et al.
Leukemia & Lymphoma|April 10, 2008
Pharmacologic markers and predictors of responses to imatinib therapy in patients with chronic myeloid leukemiaRichard E Clark, Andrea Davies, Munir Pirmohamed, et al.
Haematologica|February 8, 2006
The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemiaLihui Wang, Katy Knight, Claire Lucas, et al.
Nucleic Acids Research|April 25, 2003
CpG oligodeoxynucleotide 5mer-induced apoptosis in MOLT-4 leukaemia cells does not require caspase 3 or new protein synthesisDavid M Tidd, Caroline M Broughton, Richard E Clark
British Journal of Haematology|March 22, 2003
The early molecular response to imatinib predicts cytogenetic and clinical outcome in chronic myeloid leukaemiaLihui Wang, Kevin Pearson, Julia E Ferguson, et al.
Blood Advances|February 22, 2021
Additional chromosomal abnormalities at chronic myeloid leukemia diagnosis predict an increased risk of progressionRichard E Clark, Jane F Apperley, Mhairi Copland, et al.
European Journal of Haematology|July 22, 2014
Evidence that the pregnane X and retinoid receptors PXR, RAR and RXR may regulate transcription of the transporter hOCT1 in chronic myeloid leukaemia cellsGemma Austin, Alison Holcroft, Natasha Rinne, et al.
Leukemia Research|January 21, 2009
T cell function in chronic myeloid leukemia and its treatment with tyrosine kinase inhibitors--clues from and for sarcoidosisMaqsood Punekar, Jecko Thachil, Rahuman Salim, et al.
Blood|January 15, 2020
Molecular monitoring during dose reduction predicts recurrence after TKI cessation in CMLAndrea Gottschalk, Ingmar Glauche, Silvia Cicconi, et al.
Pageof 12